BC Cancer Agency
Long-Read Sequencing Data Analysis Reveals Advanced Cancer Features
Researchers delved into data for 189 tumors sequenced in the "Long-Read Personalized OncoGenomics" project to ID complex structural variants and methylation marks, among other tumor insights.
Personalis, BC Cancer Partner on Study of ctDNA MRD Tests for Colorectal, Pancreatic Cancers
The company will work with the Canadian health service to assess the potential health and economic impact of its molecular residual disease test.
The British Columbia-based developers are not trying to commercialize DLP Plus, but the platform is now being adopted in the US and UK.
Structural Variants in Advanced Cancers Point to Effect of Treatment, Suggest Resistance Mechanisms
The expressions of hundreds of genes in advanced cancers change in relation to nearby structural variant breakpoints, a new analysis has found.
Roche, Canadian Organizations Launch Real-World Evidence Framework in British Columbia
The aim within the initiative is to generate and assess real-world evidence, and use the data to support reimbursement for precision oncology therapies.